UNSW Sydney’s Centre for Molecular Oncology will partner with not-for-profit cancer genomics leader Omico to deliver the national precision oncology program PrOSPeCT.
A new modelling study led by UNSW predicts demand for cancer surgery will rise by 52 per cent within two decades, with low-income countries bearing the greatest burden.
Dr David Mizrahi speaks about his research into the role of exercise during and after chemotherapy for sufferers of paediatric and ovarian cancers.
UNSW's David Goldstein has been awarded for his continued dedication to improving global health through an oncology project in central Vietnam.
Children fighting a life-threatening form of cancer could be treated with a revolutionary anti-cancer therapy as early as next year, following the formation of a research alliance to fast-track development of a drug pioneered by UNSW researchers.
Generation Y is becoming more complacent about the risk of melanoma and other types of skin cancer, according to a UNSW researcher.